Characteristics of prostate cancer detected by digital rectal examination only.

Characteristics of prostate cancer detected by digital rectal examination only. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Characteristics of prostate cancer detected by digital rectal examination only. Abstract Text:

Onisuru T Okotie,Kimberly A Roehl,Misop Han,Stacy Loeb,Sara N Gashti,William J Catalona,Onisuru T Okotie,Kimberly A Roehl,Misop Han,Stacy Loeb,Sara N Gashti,William J Catalona,Onisuru T Okotie,Kimberly A Roehl,Misop Han,Stacy Loeb,Sara N Gashti,William J Catalona,

OBJECTIVES: To examine clinical and pathologic features and postoperative survival outcomes of men with prostate cancer detected by digital rectal examination (DRE) alone, elevated prostate-specific antigen (PSA) level alone, or abnormalities in both. METHODS: From 1989 to 2001, approximately 36,000 men participated in a prostate cancer screening study. We recommended biopsy for a PSA level greater than 4.0 ng/mL (until 1995) or greater than 2.5 ng/mL (after 1995) or DRE findings suspicious for cancer. The clinical and pathologic features were compared between patients with cancer detected by DRE alone and those with cancer detected by an elevated PSA level, regardless of DRE findings. We also evaluated progression-free survival, overall survival, and cancer-specific survival. RESULTS: Overall 303 men were diagnosed with prostate cancer by DRE alone, 1426 because of PSA level alone, and 504 by abnormal results on both tests. Of the cancers detected by DRE alone, 60 (20%) were non-organ-confined and 56 (20%) had a Gleason score of 7 or higher. Prostate cancers detected because of abnormalities in both PSA level and DRE results were significantly more likely to have adverse pathologic features, as well as lower rates of progression-free survival, overall survival, and cancer-specific survival than those detected by either test alone (all P <0.0001). CONCLUSIONS: A substantial proportion of prostate cancers detected by DRE at PSA levels less than 4 ng/mL have features associated with clinically aggressive tumors. The omission of DRE from screening protocols might compromise treatment outcomes because many of the cancers detected by DRE alone are potentially curable but may have worse outcomes by the time PSA also reaches a higher level.

Characteristics of prostate cancer detected by digital rectal examination only. Publishing Authors By Initials

OT Okotie,KA Roehl,M Han,S Loeb,SN Gashti,WJ Catalona,OT Okotie,KA Roehl,M Han,S Loeb,SN Gashti,WJ Catalona,OT Okotie,KA Roehl,M Han,S Loeb,SN Gashti,WJ Catalona,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Characteristics of prostate cancer detected by digital rectal examination only. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Urology

VOLUME: 70

Page Numbers: 1117-20

Journal Abbreviation: Urology

ISSN: 1527-9995

DAY: 25

MONTH: Dec

YEAR: 2007

Characteristics of prostate cancer detected by digital rectal examination only. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 366151

Characteristics of prostate cancer detected by digital rectal examination only. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Characteristics of prostate cancer detected by digital rectal examination only. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Characteristics of prostate cancer detected by digital rectal examination only.

AFFILIATION: Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Urology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Characteristics of prostate cancer detected by digital rectal examination only Related Publications

• Characteristics of prostate cancer detected by digital rectal examination only.
• Clinical utility of measurements of free and total prostate-specific antigen (PSA): a review.
• Combined Prostate-specific Antigen Density and Biopsy Features to Predict "Clinically Insignificant" Prostate Cancer.
• Comparison of prostate specific antigen velocity in screened versus referred patients with prostate cancer.
• Complications of open radical retropubic prostatectomy in potential candidates for active monitoring.
• Improved stage and grade-specific progression-free survival rates after radical prostatectomy in the PSA era.
• Long-Term Rates of Undetectable PSA with Initial Observation and Delayed Salvage Radiotherapy after Radical Prostatectomy.
• Mutant L Homologue 1 (MLH1): a possible new immunohistochemical marker for prostatic cancer.
• Open radical retropubic prostatectomy.
• Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.
• Relationship of prostate-specific antigen velocity to histologic findings in a prostate cancer screening program.
• Tumor Characteristics of Carriers and Noncarriers of the deCODE 8q24 Prostate Cancer Susceptibility Alleles.
• Under diagnosis and over diagnosis of prostate cancer.
• What to Do with an Abnormal PSA Test.